UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) |
Class A
Previously Reported
Ordinary Shares
|
Class A
Ordinary Shares
|
Class B
Previously Reported
Ordinary Shares
|
Class B
Ordinary Shares
|
Subscription receivable |
Additional paid-in capital |
Retained earnings (Accumulated deficits) |
Accumulated other comprehensive income (loss) |
Statutory reserve |
Total shareholders’ Equity |
Non- controlling interests |
Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BALANCE at Oct. 31, 2022 | $ 1,000 | $ 500 | $ (1,500) | $ 1,210,094 | $ (9,330) | $ (178,658) | $ 1,022,106 | |||||
| BALANCE (in Shares) at Oct. 31, 2022 | 10,000,000 | 5,000,000 | ||||||||||
| Net income (loss) | 1,859,613 | 1,859,613 | ||||||||||
| Statutory reserve | (188,144) | $ 188,144 | ||||||||||
| Foreign currency translation adjustments | (67,065) | (67,065) | ||||||||||
| BALANCE at Oct. 31, 2023 | 1,000 | 500 | (1,500) | 1,210,094 | 1,662,139 | (245,723) | 188,144 | 2,814,654 | ||||
| BALANCE (in Shares) at Oct. 31, 2023 | 10,000,000 | 5,000,000 | ||||||||||
| Net income (loss) | 2,103,357 | 2,103,357 | ||||||||||
| Statutory reserve | (214,477) | 214,477 | ||||||||||
| Foreign currency translation adjustments | 99,298 | 99,298 | ||||||||||
| BALANCE at Oct. 31, 2024 | $ 1,000 | $ 500 | (1,500) | 1,210,094 | 3,551,019 | (146,425) | 402,621 | 5,017,309 | ||||
| BALANCE (in Shares) at Oct. 31, 2024 | 10,000,000 | 400,000 | 5,000,000 | 200,000 | ||||||||
| Issuance of ordinary shares upon Initial Public Offering (“IPO”) | $ 125 | 3,035,160 | 3,035,285 | |||||||||
| Issuance of ordinary shares upon Initial Public Offering (“IPO”) (in Shares) | 50,000 | |||||||||||
| Net income (loss) | (479,165) | (479,165) | ||||||||||
| Statutory reserve | (17,610) | 17,610 | ||||||||||
| Foreign currency translation adjustments | (131,684) | (131,684) | ||||||||||
| BALANCE at Apr. 30, 2025 | $ 1,125 | $ 500 | (1,500) | 4,245,254 | 3,054,244 | (278,109) | 420,231 | 7,441,745 | ||||
| BALANCE (in Shares) at Apr. 30, 2025 | 450,000 | 200,000 | ||||||||||
| BALANCE at Oct. 31, 2024 | $ 1,000 | $ 500 | (1,500) | 1,210,094 | 3,551,019 | (146,425) | 402,621 | 5,017,309 | ||||
| BALANCE (in Shares) at Oct. 31, 2024 | 10,000,000 | 400,000 | 5,000,000 | 200,000 | ||||||||
| Issuance of ordinary shares upon Initial Public Offering (“IPO”) | $ 125 | 3,012,788 | 3,012,913 | |||||||||
| Issuance of ordinary shares upon Initial Public Offering (“IPO”) (in Shares) | 1,250,000 | |||||||||||
| Net income (loss) | (322,202) | (322,202) | ||||||||||
| Statutory reserve | (110,111) | 110,111 | ||||||||||
| Foreign currency translation adjustments | 19,651 | 19,651 | ||||||||||
| BALANCE at Oct. 31, 2025 | $ 1,125 | $ 500 | (1,500) | 4,222,882 | 3,118,706 | (126,774) | 512,732 | $ 7,727,671 | 7,727,671 | |||
| BALANCE (in Shares) at Oct. 31, 2025 | 11,250,000 | 450,000 | 5,000,000 | 200,000 | ||||||||
| Issuance of ordinary shares upon Initial Public Offering (“IPO”) | $ 1,334 | 7,036,103 | 7,037,437 | 7,037,437 | ||||||||
| Issuance of ordinary shares upon Initial Public Offering (“IPO”) (in Shares) | 533,334 | |||||||||||
| Ordinary shares issued upon cashless exercise of the warrants | $ 1,579 | (1,579) | ||||||||||
| Ordinary shares issued upon cashless exercise of the warrants (in Shares) | 631,794 | |||||||||||
| Net income (loss) | (1,071,916) | (1,071,916) | $ (2,177) | (1,074,093) | ||||||||
| Statutory reserve | (153,500) | 153,500 | ||||||||||
| Foreign currency translation adjustments | 255,304 | 255,304 | (40) | 255,264 | ||||||||
| BALANCE at Apr. 30, 2026 | $ 4,038 | $ 500 | $ (1,500) | $ 11,257,406 | $ 1,893,290 | $ 128,530 | $ 666,232 | $ 13,948,496 | $ (2,217) | $ 13,946,279 | ||
| BALANCE (in Shares) at Apr. 30, 2026 | 1,615,128 | 200,000 |
| X | ||||||||||
- Definition Amount of equity accumulated in a statutory reserve that has been appropriated from retained earnings or other equity in accordance with applicable statutory or regulatory requirements and is restricted or designated for specified purposes. No definition available.
|
| X | ||||||||||
- Definition Number of ordinary shares issued upon exercise of the warrants. No definition available.
|
| X | ||||||||||
- Definition Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|